Management Team / Advisory Board Bios
Repeat Founder
Founder has started a previous company funded with $2M+, Jonathan Cohen CEOJohns Hopkins MS in Biotech + 25 yrs leading medical diagnostics: partnerships, marketing, IP, & finance. Secured $25M+ in funding & championed pro-biotech legislation. Early pioneer & inventor in multi-cancer early detection blood testing., Michael Lebowitz Ph.D., Chief Scientific OfficerJohns Hopkins Ph.D. (Biochem, Cell & Mol Bio) with 30+ yrs life sciences R&D in cancer Dx & Tx. Adjunct Prof. (Biotech) at Johns Hopkins & U. of MD Baltimore County., Jiming Zhou Ph.D., Chief Operation Officer 20+ yrs academia & industry. Led $330M pharma project. Managed Covid testing for 20/20: 400,000+ tests, peak 3,000+ tests/day., John Compton Ph.D., Board Chair20/20 Chair & BioDx co-founder (sold to Opko). Led BioReference as VP (2007-2013). MIT BS (Bio/Physics), UC Berkeley Ph.D. (Biophysics)., Michael A. RossM.D., Board Member20/20 Director (2016-present). Grew Euclid Systems revenue 5x in 5 years (CEO 2015-2020). GWU Ob-Gyn clinical professor (since 1979). Boards experience in biotech & medical devices. BS (Chem/Bio) & MD., Anne ShiflettActing CFO30+ yrs mgmt, finance & accounting (19 yrs life sciences). Secured $200M+ funding (strategic, PE, VC, etc.). Led company from turnaround to $1.2B sale.